Our Approach & Expertise

Over the past four decades, physician-scientists here at our Center have pioneered new chemotherapy regimens that have improved long-term, disease-free survival rates of children and adolescents diagnosed with lymphoma. Other treatment advances Center physicians have contributed include the first conclusive study showing that routine radiation treatment is not necessary for all children with non-Hodgkin's lymphoma. In the past ten years, our Center's pioneering work, both with new chemotherapy regimes and in peripheral stem cell transplants, has led to improved disease-free survival rates in children with recurrent lymphomas. In Hodgkin Lymphoma, the disease free survival rate is 98 percent and in non-Hodgkin Lymphoma 80 percent.

At Memorial Sloan-Kettering, specialists in medical oncology, radiology, pathology, and surgery work together as a multidisciplinary team in order to provide the best possible care to patients with lymphoma.

As part of this multidisciplinary team, a medical social worker, a child life specialist, and specialists from the Integrative Medicine service at Memorial Sloan-Kettering complement the traditional therapies for pediatric patients with lymphoma by offering ways to enhance the quality of life of patients undergoing intensive treatment regimens.